The trademark application ZOTAGCLA was filed by Astellas Pharma Inc., a corporation established under the laws of Japan (the "Applicant"). The application was published for oppositions on March 29, 2022, and it was registered by office on July 6, 2022 without any oppositions.
The application was filed in English (Spanish was selected as the second language).